Author Interviews, Lancet, Pulmonary Disease / 14.02.2014
COPD: Treatment with twice daily N-acetylcysteine 600 mg
MedicalResearch.com Interview with:
Jinping Zheng MD FACCP
on behalf of Prof. Nanshan Zhong
--Jinping Zheng, MD, FCCP
Guangzhou Institute of Respiratory Disease
First Affiliated Hospital of Guangzhou Medical University
151 Yanjiang Rd. Guangzhou 510120, China
MedicalResearch.com: What are the main findings of the study?
Answer: PANTHEON is the largest, evidence-based study of long-term treatment with N-acetylcysteine (NAC) in COPD patients conducted to date. The main finding of this study is that 1-year of treatment with high dose NAC (600mg twice daily) was effective at reducing exacerbations in patients with COPD, especially in the earlier stage [GOLD II (moderate) of disease. NAC was well tolerated.
(more…)